Global Fluorescent Immunoassay Market Growth (Status and Outlook) 2025-2031

Global Fluorescent Immunoassay Market Growth (Status and Outlook) 2025-2031

The global Fluorescent Immunoassay market size is predicted to grow from US$ 147 million in 2025 to US$ 162 million in 2031; it is expected to grow at a CAGR of 1.7% from 2025 to 2031.

Fluorescent immunoassay has the advantages of high specificity, high sensitivity and good practicability, so it is used to measure bioactive compounds with low content, such as proteins (enzymes, antibodies), hormones (thyroid hormones, phthalein hormones), drugs and microorganisms.

The market for fluorescent immunoassays is growing due to their sensitivity and versatility. Trends include the development of multiplex assays capable of detecting multiple analytes simultaneously.

LPI (LP Information)' newest research report, the “Fluorescent Immunoassay Industry Forecast” looks at past sales and reviews total world Fluorescent Immunoassay sales in 2024, providing a comprehensive analysis by region and market sector of projected Fluorescent Immunoassay sales for 2025 through 2031. With Fluorescent Immunoassay sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fluorescent Immunoassay industry.

This Insight Report provides a comprehensive analysis of the global Fluorescent Immunoassay landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Fluorescent Immunoassay portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Fluorescent Immunoassay market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fluorescent Immunoassay and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fluorescent Immunoassay.

This report presents a comprehensive overview, market shares, and growth opportunities of Fluorescent Immunoassay market by product type, application, key players and key regions and countries.

Segmentation by Type:
ELISA
Rapid Test

Segmentation by Application:
Infectious Diseases
Endocrinology
Oncology

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
F.Hoffmann-La Roche Ltd(Switzerland)
Siemens AG(Germany)
Abbott Laboratories(U.S.)
Beckman Coulter(U.S.)
Ortho-Clinical Diagnostics(U.S.)
bioMerieux SA(France)

Please note: The report will take approximately 2 business days to prepare and deliver.